Golden Throat Holdings Group Company Limited 6896.HK Stock
Golden Throat Holdings Group Company Limited Price Chart
Golden Throat Holdings Group Company Limited 6896.HK Financial and Trading Overview
Contents
- Golden Throat Holdings Group Company Limited Price Chart
- Golden Throat Holdings Group Company Limited 6896.HK Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of Golden Throat Holdings Group Company Limited
- Q&A For Golden Throat Holdings Group Company Limited Stock
| Golden Throat Holdings Group Company Limited stock price | 3.77 HKD |
| Previous Close | 2.44 HKD |
| Open | 2.44 HKD |
| Bid | 2.49 HKD x 0 |
| Ask | 2.5 HKD x 0 |
| Day's Range | 2.44 - 2.5 HKD |
| 52 Week Range | 1.4 - 2.91 HKD |
| Volume | 270K HKD |
| Avg. Volume | 220.77K HKD |
| Market Cap | 1.85B HKD |
| Beta (5Y Monthly) | -0.217021 |
| PE Ratio (TTM) | 5.952381 |
| EPS (TTM) | 0.51 HKD |
| Forward Dividend & Yield | 0.36 (12.95%) |
| Ex-Dividend Date | June 16, 2023 |
| 1y Target Est | N/A |
6896.HK Valuation Measures
| Enterprise Value | 1.4B HKD |
| Trailing P/E | 5.952381 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.8631339 |
| Price/Book (mrq) | 1.2007685 |
| Enterprise Value/Revenue | 1.414 |
| Enterprise Value/EBITDA | 3.523 |
Trading Information
Golden Throat Holdings Group Company Limited Stock Price History
| Beta (5Y Monthly) | -0.217021 |
| 52-Week Change | 40.70% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2.91 HKD |
| 52 Week Low | 1.4 HKD |
| 50-Day Moving Average | 2.73 HKD |
| 200-Day Moving Average | 2.15 HKD |
6896.HK Share Statistics
| Avg. Volume (3 month) | 220.77K HKD |
| Avg. Daily Volume (10-Days) | 296.4K HKD |
| Shares Outstanding | 739.3M |
| Float | 693.41M |
| Short Ratio | N/A |
| % Held by Insiders | 69.79% |
| % Held by Institutions | 0.29% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.318 |
| Trailing Annual Dividend Yield | 13.03% |
| 5 Year Average Dividend Yield | 725.00% |
| Payout Ratio | 0.4017 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 28.34% |
| Operating Margin (ttm) | 36.62% |
| Gross Margin | 72.67% |
| EBITDA Margin | 40.12% |
Management Effectiveness
| Return on Assets (ttm) | 10.68% |
| Return on Equity (ttm) | 19.36% |
Income Statement
| Revenue (ttm) | 992.01M HKD |
| Revenue Per Share (ttm) | 1.34 HKD |
| Quarterly Revenue Growth (yoy) | 52.00% |
| Gross Profit (ttm) | N/A |
| EBITDA | 398.02M HKD |
| Net Income Avi to Common (ttm) | 281.22M HKD |
| Diluted EPS (ttm) | 0.42 |
| Quarterly Earnings Growth (yoy) | 111.50% |
Balance Sheet
| Total Cash (mrq) | 925.52M HKD |
| Total Cash Per Share (mrq) | 1.25 HKD |
| Total Debt (mrq) | 272.59M HKD |
| Total Debt/Equity (mrq) | 17.71 HKD |
| Current Ratio (mrq) | 2.443 |
| Book Value Per Share (mrq) | 2.082 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 271.15M HKD |
| Levered Free Cash Flow (ttm) | 124.15M HKD |
Profile of Golden Throat Holdings Group Company Limited
| Country | Hong Kong |
| State | N/A |
| City | Liuzhou |
| Address | No. 28 Fengxiang Road |
| ZIP | N/A |
| Phone | 86 77 2282 5718 |
| Website | https://www.goldenthroat.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 853 |
Golden Throat Holdings Group Company Limited, an investment holding company, manufactures and sells pharmaceutical, healthcare food, and other products in the People's Republic of China. The company offers Golden Throat Lozenges over-the-counter medicine to relieve symptoms of sore and dry throat, and hoarse voice caused by acute pharyngitis. It also provides Golden Throat Lozenge series products, which includes Dule Lozenges; sugar-free Dule Lozenges; and other sugar free flavors, such as orange, fructus momordicae, chrysanthemum, American ginseng, and hawthorn. In addition, the company offers Yinxingye tablets to facilitate blood circulation, remove blood stasis, and dredge energy channels; Golden Throat intestinal series; and Golden Throat Compound Probiotic Lozenges. The company also exports its products to the United States, Canada, Japan, the European Union, Australia, Southeast Asia, Middle East, Mexico, and Africa. Golden Throat Holdings Group Company Limited was founded in 1956 and is headquartered in Liuzhou, the People's Republic of China.
Q&A For Golden Throat Holdings Group Company Limited Stock
What is a current 6896.HK stock price?
Golden Throat Holdings Group Company Limited 6896.HK stock price today per share is 3.77 HKD.
How to purchase Golden Throat Holdings Group Company Limited stock?
You can buy 6896.HK shares on the HKSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Golden Throat Holdings Group Company Limited?
The stock symbol or ticker of Golden Throat Holdings Group Company Limited is 6896.HK.
Which industry does the Golden Throat Holdings Group Company Limited company belong to?
The Golden Throat Holdings Group Company Limited industry is Drug Manufacturers-Specialty & Generic.
How many shares does Golden Throat Holdings Group Company Limited have in circulation?
The max supply of Golden Throat Holdings Group Company Limited shares is 739.3M.
What is Golden Throat Holdings Group Company Limited Price to Earnings Ratio (PE Ratio)?
Golden Throat Holdings Group Company Limited PE Ratio is 7.39215700 now.
What was Golden Throat Holdings Group Company Limited earnings per share over the trailing 12 months (TTM)?
Golden Throat Holdings Group Company Limited EPS is 0.51 HKD over the trailing 12 months.
Which sector does the Golden Throat Holdings Group Company Limited company belong to?
The Golden Throat Holdings Group Company Limited sector is Healthcare.